Olmibite Beta 25 Tablet ER
Olmibite Beta 25 Tablet ER
Olmesartan Medoxomil (20mg) + Metoprolol Succinate (25mg)
Olmecaid M 25 Tablet ER
Medicaid Labs LLP
Metoprolol Succinate 25mg
Pack Size
1 units
Price
Save ₹48
that's 40% off!
About This Medicine
Product description & overview
Olmixbite Beta 25 Tablet ER: A Comprehensive Cardiovascular Solution
Olmixbite Beta 25 Tablet ER (Olmesartan Medoxomil 20 mg + Metoprolol Succinate 25 mg) is a once-daily extended-release formulation designed for the management of hypertension. This combination therapy provides effective blood pressure control through dual action:
* Olmesartan Medoxomil: A long-acting angiotensin II receptor blocker (ARB), effectively reduces blood volume and lowers blood pressure by blocking the effects of the hormone aldosterone, thereby reducing fluid retention.
* Metoprolol Succinate: A beta blocker that decreases heart rate and contractility to further lower blood pressure.
Olmixbite Beta 25 Tablet ER offers a streamlined treatment approach with consistent daily dosing for improved adherence. The extended-release formulation ensures sustained delivery of both active ingredients, providing long-lasting effects throughout the day.
Note: This product should be used under the guidance of a healthcare professional. Consult your doctor before starting or stopping any medication.
Active composition
Olmesartan Medoxomil 20 mg
+1 more active ingredient
About Olmesartan Medoxomil
Olmesartan Medoxomil is an antihypertensive medication used to treat high blood pressure. It works by blocking angiotensin II receptors, leading to vasodilation and reduced blood pressure. Olmesartan Medoxomil is effective for managing hypertension. In summary, it is essential for cardiovascular health.
How It Works
Olmesartan Medoxomil blocks angiotensin II receptors, preventing vasoconstriction and lowering blood pressure.
All Active Ingredients
Metoprolol Succinate
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Olmibite Beta 25 Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Pregnancy
Olmibite Beta 25 Tablet ER is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Driving
Olmibite Beta 25 Tablet ER should be used with caution in patients with severe kidney disease. Dose adjustment of Olmibite Beta 25 Tablet ER may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment.
Exercise Caution
Breastfeeding
Olmibite Beta 25 Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Olmibite Beta 25 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Olmibite Beta 25 Tablet ER may be needed. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Olmibite Beta 25 Tablet ER